Literature DB >> 32062311

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.

F Passiglia1, L Bertolaccini2, M Del Re3, F Facchinetti4, R Ferrara5, T Franchina6, U Malapelle7, J Menis8, A Passaro9, S Pilotto10, S Ramella11, G Rossi12, R Trisolini13, S Novello14.   

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the diagnosis and treatment of patients with early and locally advanced non-small cell lung cancer. In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed these topics, analyzing available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical practice guidelines; Early disease; Locally advanced disease; Non-small cell lung cancer; Recommendations

Year:  2020        PMID： 32062311     DOI： 10.1016/j.critrevonc.2019.102862

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


  9 in total

1.  Genomic Analysis Reveals the Prognostic and Immunotherapeutic Response Characteristics of Ferroptosis in Lung Squamous Cell Carcinoma.

Authors:  Yinhe Feng; Xingyu Xiong; Yubin Wang; Ding Han; Chunfang Zeng; Hui Mao
Journal:  Lung       Date:  2022-05-05       Impact factor: 2.584

2.  Efficacy and safety of camrelizumab (a PD-1 inhibitor) combined with chemotherapy as a neoadjuvant regimen in patients with locally advanced non-small cell lung cancer.

Authors:  Xinlei Hou; Xueliang Shi; Jie Luo
Journal:  Oncol Lett       Date:  2022-05-17       Impact factor: 3.111

Review 3.  GOECP/SEOR radiotheraphy guidelines for non-small-cell lung cancer.

Authors:  Núria Rodríguez De Dios; Arturo Navarro-Martin; Cristina Cigarral; Rodolfo Chicas-Sett; Rafael García; Virginia Garcia; Jose Antonio Gonzalez; Susana Gonzalo; Mauricio Murcia-Mejía; Rogelio Robaina; Amalia Sotoca; Carmen Vallejo; German Valtueña; Felipe Couñago
Journal:  World J Clin Oncol       Date:  2022-04-24

Review 4.  Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.

Authors:  Zhe Zhang; Sen Yang; Yanfang Ma; Hanqiong Zhou; Xuan Wu; Jing Han; Jiabao Hou; Lidan Hao; Jonathan D Spicer; Young Wha Koh; Mariano Provencio; Noemi Reguart; Tetsuya Mitsudomi; Qiming Wang
Journal:  Transl Lung Cancer Res       Date:  2021-06

Review 5.  Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations.

Authors:  Antonio Marchetti; Fiamma Buttitta; Emanuela D'Angelo
Journal:  Oncotarget       Date:  2022-03-03

6.  Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer.

Authors:  Luca Bertolaccini; Elena Prisciandaro; Juliana Guarize; Lara Girelli; Giulia Sedda; Niccolò Filippi; Filippo de Marinis; Lorenzo Spaggiari
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

Review 7.  The Interdisciplinary Management of Lung Cancer in the European Community.

Authors:  Luca Bertolaccini; Shehab Mohamed; Claudia Bardoni; Giorgio Lo Iacono; Antonio Mazzella; Juliana Guarize; Lorenzo Spaggiari
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

Review 8.  Testing EGFR with Idylla on Cytological Specimens of Lung Cancer: A Review.

Authors:  Alessandro Caputo; Angela D'Ardia; Francesco Sabbatino; Caterina Picariello; Chiara Ciaparrone; Pio Zeppa; Antonio D'Antonio
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

9.  Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist.

Authors:  Yongjie Yang; Jingli Lu; Yanfang Ma; Chen Xi; Jian Kang; Qiwen Zhang; Xuedong Jia; Kefeng Liu; Shuzhang Du; Florian Kocher; Andreas Seeber; Cesare Gridelli; Mariano Provencio; Nobuhiko Seki; Yusuke Tomita; Xiaojian Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.